License and Supply Agreement Sample Clauses

License and Supply Agreement. The Parties hereby amend the terms of the License and Supply Agreement in substantially the same form as attached hereto as Exhibit B and concurrently herewith shall execute same.

Get the Official Word Add-in

License and Supply Agreement. This Agreement made by and between Sigma Designs Inc., a California corporation having a principal place of business at 0000 XxXxxxxx Xxxx, Milpitas, CA 95035 ('Sigma Designs'), and LICENSEE., Inc., a corporation having offices at the address as per below ('LICENSEE') shall have an effective date as per below, ('Effective Date'), (Sigma Designs and LICENSEE being sometimes hereinafter referred to individually as 'Party' and collectively as 'Parties'.)

License and Supply Agreement. This License and Supply Agreement (“Agreement”) is entered into as of October 15th, 1999 (the “Effective Date”) by and between Xcyte Therapies, Inc., a Delaware corporation having a principal place of business at 0000 Xxxxxxx Xxx Xxxxx, Xxxxx 000, Xxxxxxx, Xxxxxxxxxx 00000, Xxxxxx Xxxxxx (“Xcyte”), and Diaclone S.A., a French corporation having a principal place of business at 1 Boulevard Xxxxxxx, X.X. 1985 F-25020 Besancon Cedex, France (“Diaclone”).

License and Supply Agreement. The License and Supply Agreement by and between the Company and the Investor, dated January 17, 1996, and as amended by (i) the Amendment to the License and Supply Agreement, dated January 22/February 4, 1998, (ii) the Addendum to the License and Supply Agreement, dated March 23, 1998; (iii) the Addendum II to the License and Supply Agreement, dated September 4, 1998; (iv) the Addendum, dated March 15, 2000, to the License and Supply Agreement and (v) the Amendment V to the License and Supply Agreement, dated January 2, 2001,(the "License and Supply Agreement") is in full force and effect and shall not have been terminated (other than for termination resulting from (A) a material breach thereof by the Investor, (B) involuntary bankruptcy against the Company as provided in Section 16.3 of the License and Supply Agreement or (C) any termination of the License and Supply Agreement pursuant to Sections 16.2 and 16.4 other than as expressly set forth below in this Section 7.3). The Investor shall not have made an Organogenesis Offer (as defined in the License and Supply Agreement) which shall have been accepted by the Company. The License and Supply Agreement shall not have been terminated pursuant to Section 16.4 thereof for reasons relating to the safety or efficacy of the Product (as defined in the License and Supply Agreement). The License and Supply Agreement shall not have been terminated by reason of the material breach or default of the Company pursuant to Section 16.2 thereof.

License and Supply Agreement. The Parties and certain Affiliates shall enter a License and Supply Agreement, in the form attached hereto as Exhibit C (the “License and Supply Agreement”).

License and Supply Agreement. 6.1 If Medeva exercises the Development Option, the parties will enter into good faith negotiations for definitive license and supply agreements covering further development, regulatory approval, manufacture, use, distribution and sale of the Product. From the date of Medeva's exercise of the Development Option, the parties shall have ninety (90) days to conclude definitive licensing and supply agreements. If at the end of such ninety (90) day period (or such longer as the parties may agree) the definitive license and supply agreements have not been concluded, neither party shall be obligated to continue to negotiate the terms of nor enter into such definitive license and supply agreement. Such agreements shall be co-exclusive (within the meaning of Article 7), worldwide agreements.

Related to License and Supply Agreement